ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (AMEX: RNN), a leader in the development of innovative therapeutics for life-threatening and life-debilitating diseases, announced today that it has selected KCSA Strategic Communications, a leading New York-based communications firm, as its investor relations agency.
